Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 4
2006 1
2008 5
2009 5
2010 4
2011 2
2012 3
2013 5
2014 6
2015 4
2016 9
2017 11
2018 9
2019 12
2020 6
2021 18
2022 19
2023 19
2024 18
2025 26
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Chisholm J, Mandeville H, Adams M, Minard-Collin V, Rogers T, Kelsey A, Shipley J, van Rijn RR, de Vries I, van Ewijk R, de Keizer B, Gatz SA, Casanova M, Hjalgrim LL, Firth C, Wheatley K, Kearns P, Liu W, Kirkham A, Rees H, Bisogno G, Wasti A, Wakeling S, Heenen D, Tweddle DA, Merks JHM, Jenney M. Chisholm J, et al. Among authors: merks jhm. Cancers (Basel). 2024 Feb 29;16(5):998. doi: 10.3390/cancers16050998. Cancers (Basel). 2024. PMID: 38473359 Free PMC article.
Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial.
Defachelles AS, Bogart E, Casanova M, Merks JHM, Bisogno G, Calareso G, Gallego Melcon S, Gatz SA, Le Deley MC, McHugh K, Probst A, Rocourt N, van Rijn RR, Wheatley K, Minard-Colin V, Chisholm JC. Defachelles AS, et al. Among authors: merks jhm. J Clin Oncol. 2021 Sep 20;39(27):2979-2990. doi: 10.1200/JCO.21.00124. Epub 2021 Aug 3. J Clin Oncol. 2021. PMID: 34343032 Clinical Trial.
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition.
Ringnalda FCAS, van Son GJF, Verweij LHG, Kim SY, Amo-Addae V, Flucke UE, Hiemcke-Jiwa LS, Langenberg KPS, Bramer JAM, Heimans L, van de Sande MAJ, van Houdt WJ, van Noesel MM, Kerstens HHD, Santoso M, Seifert G, Delattre O, Scotlandi K, Geoerger B, Merks JHM, Molenaar JJ, van Boxtel R, van de Wetering M, Sanders K, Clevers H. Ringnalda FCAS, et al. Among authors: merks jhm. Nat Commun. 2025 Aug 21;16(1):7689. doi: 10.1038/s41467-025-62673-2. Nat Commun. 2025. PMID: 40841360 Free PMC article.
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial.
Bisogno G, Chisholm J, Hladun R, De Salvo GL, Guerin F, Casanova M, Mandeville H, Alaggio R, Coppadoro B, Orbach D, Ferrari A, van Rijn R, Defachelles AS, Ben-Arush M, Glosli H, Cesen M, Merks JHM, Minard-Colin V. Bisogno G, et al. Among authors: merks jhm. J Clin Oncol. 2025 Jun;43(16):1856-1862. doi: 10.1200/JCO-24-02850. Epub 2025 Mar 7. J Clin Oncol. 2025. PMID: 40053891 Clinical Trial.
A comprehensive overview of liquid biopsy applications in pediatric solid tumors.
Janssen FW, Lak NSM, Janda CY, Kester LA, Meister MT, Merks JHM, van den Heuvel-Eibrink MM, van Noesel MM, Zsiros J, Tytgat GAM, Looijenga LHJ. Janssen FW, et al. Among authors: merks jhm. NPJ Precis Oncol. 2024 Aug 3;8(1):172. doi: 10.1038/s41698-024-00657-z. NPJ Precis Oncol. 2024. PMID: 39097671 Free PMC article. Review.
Maintenance Chemotherapy for Patients with Rhabdomyosarcoma.
Bisogno G, Minard-Colin V, Jenney M, Ferrari A, Chisholm J, Di Carlo D, Hjalgrim LL, Orbach D, Merks JHM, Casanova M. Bisogno G, et al. Cancers (Basel). 2023 Aug 7;15(15):4012. doi: 10.3390/cancers15154012. Cancers (Basel). 2023. PMID: 37568826 Free PMC article. Review.
Childhood, Adolescent and Young Adult Poor-Prognosis Rhabdomyosarcoma.
Wasti AT, Bisogno G, Hladun R, Defachelles AS, Casanova M, Breunis WB, Gatz SA, Schoot RA, Ferrari A, Jenney M, Alaggio R, Davila Fajardo R, Terwisscha van Scheltinga S, Shipley J, Meister MT, R van Rijn R, Anderson J, Sparber-Sauer M, Chisholm JC, Merks JHM. Wasti AT, et al. Among authors: merks jhm. Cancers (Basel). 2025 Sep 23;17(19):3100. doi: 10.3390/cancers17193100. Cancers (Basel). 2025. PMID: 41097629 Free PMC article. Review.
Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade Osteosarcoma.
van Ewijk R, Hiemcke-Jiwa LS, Hehir-Kwa JY, Gaspar N, Haveman LM, Flucke UE, Dandis R, van Tuil M, Janda CY, van de Sande MAJ, van der Heijden L, Koudijs MJ, Merks JHM, Tops BBJ, Marchais A, Kester LA. van Ewijk R, et al. Among authors: merks jhm. JCO Precis Oncol. 2025 May;9:e2400855. doi: 10.1200/PO-24-00855. Epub 2025 May 29. JCO Precis Oncol. 2025. PMID: 40440582 Free PMC article.
167 results